2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Assoc
4 days ago
- #pulmonary embolism
- #clinical guidelines
- #anticoagulant therapy
- The 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline provides comprehensive recommendations for the evaluation and management of acute pulmonary embolism (PE) in adults.
- Introduces the AHA/ACC Acute Pulmonary Embolism Clinical Categories for better severity classification, prognosis assessment, and therapeutic decision-making.
- Based on a comprehensive literature search from February 2024 to October 2024, with key studies added until April 2025.
- Focuses on evidence-based and patient-centered approaches from symptom onset through clinical follow-up.
- Covers risk assessment, clinical diagnosis, diagnostic imaging, and management strategies including pharmacological and interventional therapies.